Rein Therapeutics, Inc. Increase (Decrease) in Other Current Assets
Rein Therapeutics, Inc. (RNTX) reported Increase (Decrease) in Other Current Assets of -$852.00 thousand for the 9-month period ending 2019-09-30, per its 10-Q filed 2019-11-07.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherCurrentAssets · last filed 2019-11-07
- Rein Therapeutics, Inc. increase (decrease) in other current assets for the quarter ending 2019-09-30 was -$161.00K.
- Rein Therapeutics, Inc. increase (decrease) in other current assets for the quarter ending 2019-06-30 was -$158.00K.
- Rein Therapeutics, Inc. increase (decrease) in other current assets for the quarter ending 2019-03-31 was -$533.00K.
- Rein Therapeutics, Inc. increase (decrease) in other current assets for the quarter ending 2018-12-31 was $0.00.
- Rein Therapeutics, Inc. increase (decrease) in other current assets for fiscal 2018 was -$15.00K.
- Rein Therapeutics, Inc. increase (decrease) in other current assets for fiscal 2017 was -$147.00K, a 118.89% decline from fiscal 2016.
- Rein Therapeutics, Inc. increase (decrease) in other current assets for fiscal 2016 was $778.00K.
| Period end | Increase (Decrease) in Other Current Assets 3 month | Increase (Decrease) in Other Current Assets 6 month | Increase (Decrease) in Other Current Assets 9 month | Increase (Decrease) in Other Current Assets 12 month |
|---|---|---|---|---|
| 2019-09-30 | -$161.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | -$319.00K derived: sum of 2 quarters · filed 2019-11-07 | -$852.00K 10-Q · filed 2019-11-07 | -$852.00K derived: sum of 4 quarters · filed 2019-11-07 |
| 2019-06-30 | -$158.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-06 | -$691.00K 10-Q · filed 2019-08-06 | -$691.00K derived: sum of 3 quarters · filed 2019-08-06 | -$691.00K derived: sum of 4 quarters · filed 2019-11-07 |
| 2019-03-31 | -$533.00K 10-Q · filed 2019-05-08 | -$533.00K derived: sum of 2 quarters · filed 2019-05-08 | -$533.00K derived: sum of 3 quarters · filed 2019-11-07 | -$537.00K derived: sum of 4 quarters · filed 2019-11-07 |
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-29 | $0.00 derived: sum of 2 quarters · filed 2019-11-07 | -$4.00K derived: sum of 3 quarters · filed 2019-11-07 | -$15.00K 10-K · filed 2019-03-29 |
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | -$4.00K derived: sum of 2 quarters · filed 2019-11-07 | -$15.00K 10-Q · filed 2019-11-07 | -$129.00K derived: sum of 4 quarters · filed 2019-11-07 |
| 2018-06-30 | -$4.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-06 | -$15.00K 10-Q · filed 2019-08-06 | -$129.00K derived: sum of 3 quarters · filed 2019-08-06 | -$103.00K derived: sum of 4 quarters · filed 2019-08-06 |
| 2018-03-31 | -$11.00K 10-Q · filed 2019-05-08 | -$125.00K derived: sum of 2 quarters · filed 2019-05-08 | -$99.00K derived: sum of 3 quarters · filed 2019-05-08 | -$162.00K derived: sum of 4 quarters · filed 2019-05-08 |
| 2017-12-31 | -$114.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-29 | -$88.00K derived: sum of 2 quarters · filed 2019-03-29 | -$151.00K derived: sum of 3 quarters · filed 2019-03-29 | -$147.00K 10-K · filed 2019-03-29 |
| 2017-09-30 | $26.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07 | -$37.00K derived: sum of 2 quarters · filed 2018-11-07 | -$33.00K 10-Q · filed 2018-11-07 | |
| 2017-06-30 | -$63.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-07 | -$59.00K 10-Q · filed 2018-08-07 | ||
| 2017-03-31 | $4.00K 10-Q · filed 2018-05-09 | |||
| 2016-12-31 | $778.00K 10-K · filed 2018-04-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |